Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Citi
Daiichi Sankyo
Dow
QuintilesIMS
Accenture
Colorcon
McKesson
Boehringer Ingelheim

Generated: November 20, 2018

DrugPatentWatch Database Preview

Drugs in Development Information for Bavituximab

« Back to Dashboard

US Patents for Bavituximab

Glossary
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Bavituximab ➤ Sign Up Multispecific constructs AbbVie Stemcentrx LLC (North Chicago, IL) ➤ Sign Up
Bavituximab ➤ Sign Up Modulators of toll-like receptor 7 Gilead Sciences, Inc. (Foster City, CA) ➤ Sign Up
Bavituximab ➤ Sign Up Modulators of pharmacokinetic properties of therapeutics Gilead Sciences, Inc. (Foster City, CA) ➤ Sign Up
Bavituximab ➤ Sign Up Stabilizing alkylglycoside compositions and methods thereof Aegis Therapeutics LLC (San Diego, CA) ➤ Sign Up
Bavituximab ➤ Sign Up Modulators of pharmacokinetic properties of therapeutics Gilead Sciences, Inc. (Foster City, CA) ➤ Sign Up
Bavituximab ➤ Sign Up Antiviral compounds Gilead Sciences, Inc. (Foster City, CA) ➤ Sign Up
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Bavituximab

Glossary
Drugname Country Document Number Estimated Expiration Related US Patent
Bavituximab Canada 2900764 2033-02-08 ➤ Sign Up
Bavituximab European Patent Office 2954056 2033-02-08 ➤ Sign Up
Bavituximab Hong Kong 1218930 2033-02-08 ➤ Sign Up
Bavituximab Japan 2016509014 2033-02-08 ➤ Sign Up
Bavituximab World Intellectual Property Organization (WIPO) 2014124326 2033-02-08 ➤ Sign Up
Bavituximab African Regional IP Organization (ARIPO) 2706 2027-06-29 ➤ Sign Up
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Accenture
Mallinckrodt
Merck
Deloitte
Cantor Fitzgerald
Dow
Argus Health
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2018 - 2019
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2018, www.DrugPatentWatch.com.
Links

Follow DrugPatentWatch: